Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TJ 9

Next Previous
X
Search
Drug Profile

TJ 9

Alternative Names: H09; Saiko-keishi-to; Sho-saiko-to; Shosaiko-toi; Shosaikoto-go-keishika-shakuyakuto; SST; TJ-9; Xiao-chai-hu-tang

Latest Information Update: 06 Jan 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tsumura
  • Developer Janssen Pharmaceutical KK; Memorial Sloan-Kettering Cancer Center; Tsumura
  • Class Antiretrovirals; Herbal medicines
  • Mechanism of Action Immunomodulators; Immunostimulants; RNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hepatitis B; Hepatitis C; HIV infections
  • No development reported Liver cancer
  • Discontinued Diabetes mellitus

Most Recent Events

  • 10 Aug 2015 No recent reports on development identified - Phase-II for Hepatitis C in USA (PO)
  • 14 Dec 2012 No development reported - Phase-II for liver cancer in USA (PO)
  • 22 Feb 2010 Phase-II development is ongoing for hepatitis C in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top